We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FDA acting Chief Information Officer (CIO) Fred Farmer is resigning effective July 22, at a time when the agency faces ever-increasing challenges in its IT program, an FDA release said.
The FDA is reorganizing the Office of Regulatory Affairs (ORA) to help it better meet ORA’s goal of increasing compliance and minimizing risk, an agency memorandum says.
A group of 39 medical, seniors' and health organizations have asked Congress to pass legislation ending or altering the practice of direct to consumer (DTC) prescription drug ads.
The U.S. Court of Appeals for the Federal Circuit May 15 vacated a lower court ruling that U.S. Surgical did not infringe on a patent owned by Applied Medical, and sent the case back to the U.S. District Court for the Central District of California for review.
Susan J. Walker will be the new director of CDER’s Division of Dermatology and Dental Products, Office of Drug Evaluation III, in the Office of New Drugs, CDER, the FDA announced May 12.
Senior citizens who were administered Merck’s arthritis medication Vioxx faced the highest risk of heart attack during their first two weeks on the drug, according to a study published in the Canadian Medical Association Journal.